$40.43
0.09 (+0.22%)
Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)
CAPS Rating:
A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.
RSS Headlines
Fool UK